Armistice Capital’s Antares Pharma, Inc. ATRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-428,000	Closed	-$1.16M	–	130
2020 Q3	$1.16M	Buy	+428,000	New	+$1.16M	0.04%	89
2019 Q4	–	Sell	-5,624,000	Closed	-$18.8M	–	90
2019 Q3	$18.8M	Sell	5,624,000 -376,000	-6%	-$1.26M	1.25%	28
2019 Q2	$19.7M	Sell	6,000,000 -4,300,000	-42%	-$14.1M	1.24%	22
2019 Q1	$31.2M	Hold	10,300,000	–	–	1.71%	17
2018 Q4	$28M	Buy	10,300,000 +1,180,000	+13%	+$3.21M	2.12%	12
2018 Q3	$30.6M	Sell	9,120,000 -2,930,000	-24%	-$9.84M	1.84%	17
2018 Q2	$31.1M	Sell	12,050,000 -510,000	-4%	-$1.32M	2.03%	14
2018 Q1	$27.6M	Buy	12,560,000 +4,960,000	+65%	+$10.9M	2.11%	17
2017 Q4	$15.1M	Buy	7,600,000 +3,400,000	+81%	+$6.77M	1.51%	17
2017 Q3	$13.6M	Sell	4,200,000 -1,500,000	-26%	-$4.86M	1.6%	15
2017 Q2	$18.4M	Sell	5,700,000 -3,000,000	-34%	-$9.66M	2.34%	10
2017 Q1	$24.7M	Sell	8,700,000 -2,300,000	-21%	-$6.53M	5.1%	1
2016 Q4	$25.6M	Sell	11,000,000 -1,300,000	-11%	-$3.03M	6.06%	1
2016 Q3	$20.7M	Sell	12,300,000 -3,130,000	-20%	-$5.26M	6.63%	1
2016 Q2	$16.2M	Buy	15,430,000 +24,297	+0.2%	+$25.5K	6.17%	1
2016 Q1	$13.4M	Buy	15,405,703 +2,165,703	+16%	+$1.88M	5.26%	1
2015 Q4	$16M	Buy	13,240,000 +4,940,000	+60%	+$5.98M	5.72%	1
2015 Q3	$14.1M	Buy	8,300,000 +1,900,000	+30%	+$3.23M	4.82%	3
2015 Q2	$13.3M	Buy	6,400,000 +2,600,000	+68%	+$5.41M	4.78%	5
2015 Q1	$10.3M	Buy	3,800,000 +1,200,000	+46%	+$3.25M	4.56%	7
2014 Q4	$6.68M	Buy	+2,600,000	New	+$6.68M	3.21%	17